Alzheon, Inc. raised $100 million in Series E financing led by Alerce Medical Technology Partners to advance the development and commercialization of oral tablet ALZ-801/Valiltramiprosate for the treatment of Alzheimer’s disease.
Amount Raised
$100 Million
Round Type
Series E
FraminghamBiotechnologyInvestors
Description
Alzheon, Inc. has raised $100 million in a Series E financing round led by Alerce Medical Technology Partners to advance the development and commercialization of its oral tablet ALZ-801/Valiltramiprosate for the treatment of Alzheimer’s disease. The funding reflects the promising prospects of their innovative science and technology in the treatment of Alzheimer’s disease.
Quick answer
Alzheon raised $100 Million in a Series E round, dated June 12, 2024. Investors: Alerce Medical Technology Partners. Alzheon is based in Framingham, Massachusetts, United States.
- How much did Alzheon raise?
- Alzheon raised $100 Million in a Series E round on June 12, 2024.
- Who invested in Alzheon?
- Alerce Medical Technology Partners is named as investors in this round.
- What does Alzheon do?
- Alzheon, Inc. is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.
- Where is Alzheon based and how big is it?
- Alzheon is based in Framingham, Massachusetts, United States. Fundz records about 31 employees.
- Who are the decision-makers at Alzheon?
- Fundz holds 1 contact at Alzheon, including the Director, Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alzheon that raised within 45 days of this round, from Fundz verified event records.
- Axe Compute Inc. raised $2.2M on July 26, 2024.
- Revi R Therapeutics raised $30M (Series A) on July 26, 2024.
- Amporin Pharmaceuticals raised $170K (Grant) on July 26, 2024.
- Confo Therapeutics raised $65M (Series B) on July 26, 2024.
- 4D Medicine raised $4.4M (Series A) on July 26, 2024.
- Endolytix Technology raised $5M on July 26, 2024.
Who to call at Alzheon, and when
A new round usually means Alzheon is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alzheon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alzheon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alzheon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alzheon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Alzheon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.